OncoHost

OncoHost is a technology company headquartered in Israel, and North Carolina, transforming the approach to precision medicine for improved patient outcomes. OncoHost’s proprietary platform, PROphet®, is a plasma-based, proteomic pattern analysis tool whose initial offering in NSCLC uses a single blood sample to guide first-line immunotherapy decision-making. OncoHost is led by an experienced team of entrepreneurs and industry experts and supported by a large-scale prospective clinical trial.